Q1 2017 TRACON Pharmaceuticals Inc Earnings Call

10/5/2017 16:30

Llamada en conferencia TRACON Pharmaceuticals Inc

TRACON Pharmaceuticals Inc Conference call or earnings call will be held on 10-may-2017 During the earnings conference call's session TRACON Pharmaceuticals Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact TRACON Pharmaceuticals Inc for this information
Schedule a conference call with QCONF and get 5 free conference calls.
We are a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration, or wet AMD, and fibrotic diseases. We are a leader in the field of endoglin biology and are using our expertise to develop antibodies that bind to the endoglin receptor. Endoglin is essential to angiogenesis, the process of new blood vessel formation, and a key contributor to the development of fibrosis, or tissue scarring. Our lead product candidate, TRC105, is an endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor, or VEGF, pathway. The VEGF pathway regulates vascular development in the embryo, or vasculogenesis, and angiogenesis.    
Leer más Llamada en conferencia

TRACON Pharmaceuticals Inc (TCON)

8910 University Center Lane, San Diego California 92122, United States